Table 1. Antibacterial activity of lipophosphonoxins DR5047, DR5026.
| MIC mg/L | ||
|---|---|---|
| DR5047 | DR5026 | |
| Enterococcus faecalis CCM 4224 | 6.25 | 3.125 |
| Staphylococcus aureus CCM 4223 | >200 | 25 |
| Bacillus subtilis | 6.25 | 3.125 |
| Streptococcus agalactiae | 6.25 | 3.125 |
| S. aureus MRSA 4591 | >200 | 25–50 |
| Staphylococcus haemolyticus 16568 | >200 | 50 |
| Enterococcus faecium VanA 419/ana | 6.25 | 3.125 |
| Staphylococcus epidermidis 8700/B | 3.125 | 3.125 |
| Clostridium perfringens | 12.5 | 12.5 |
| Bacteroides fragilis | 6.25 | 12.5 |
| Peptostreptococcus anaerobius | 1.56 | 1.56 |